Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment.

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in the context of celiac disease and gluten sensitivity, published as a clinical trial.

A prospective, multicenter study of patients with Ullrich-Turner syndrome (UTS) was conducted to estimate the prevalence of autoantibodies to tissue transglutaminase (tTg), thyroid stimulating hormone receptor (TSH-R), thyroglobulin (TG) and thyroid peroxidase (TPO) in relation to adult height after long-term growth hormone (GH) treatment.

Serum samples of 120 patients were obtained for central measurements of TSH, thyroxine (T4) and free T4 and autoantibodies by standard immunoassays.

Who Took Part

According to the abstract, 120 patients were involved.

By PubMed's age tags, the people studied were teenagers and adults, women only.

How the Study Was Run

The researchers set it up as a multicenter study.

More than one site took part, so the patients came from several places.

What Was Measured

Serum samples of 120 patients were obtained for central measurements of TSH, thyroxine (T4) and free T4 and autoantibodies by standard immunoassays.

PubMed files the paper under topics including Anthropometry, Autoantibodies, Body Height, Celiac Disease, Chromosome Aberrations, Chromosomes, Human, X and Gonadal Dysgenesis.

What This Means in Plain Language

The paper is a multicenter study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 120 patients in people with celiac disease and gluten sensitivity.

The publication is from 2006 (Journal of pediatric endocrinology & metabolism : JPEM), a journal based in Germany.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, Celiac disease and gluten sensitivity research.